Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentation of - PR Newswire (press release) PDF Print
PR Newswire (press release)Zerenex has recently completed a Phase 2 clinical program as a treatment for hyperphosphatemia (elevated phosphate levels) in patients with end-stage renal

... read more

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.